Objective To analyze the characteristics of thyroid function and the relationship with cardiac
structure and function in maintenance hemodialysis (MHD) patients. Methods A total of 83 patients on regular hemodialysis for more than 3 months at The Affiliated Hospital of Xuzhou Medical University during the
period from January 2019 to December 2020 were enrolled in this study. Thyroid function characteristics of
the patients and the relationship with heart structure and function were analyzed. Results Thyroid dysfunction was found in 30 (36.1%) cases, of which most had a decrease of FT3 (10.8%) and an increase of TSH
(13.3% ). Compared with the thyroid normal group, HDL (t=2.594 P=0.011) was lower, and serum LDL
(t=2.520 P=0.015), triglycerides (Z=2.796, P=0.005) and C-reactive protein (CRP) (Z=2.067, P=0.009) were
higher in the thyroid dysfunction group; in addition, the left atrium diameter (t=2.373, P=0.020), left ventricular diastolic end diameter (t=2.390 P=0.021), left ventricular posterior diastolic wall thickness (t=2.561,
P=0.014), interventricular septal thickness (t=2.688, P=0.010) and left ventricular mass index (t=3.785,
P＜0.001) were higher, and the left ventricular ejection fraction (t=3.721, P＜0.001) was lower in the thyroid
dysfunction group. Patients with left ventricular hypertrophy had older age (t=2.159, P=0.034), longer dialysis
age (Z=2.769, P=0.006), higher levels of CRP (Z=4.196, P＜0.001), LDL (t=3.059, P=0.003), parathyroid hormone (PTH) (Z=2.139, P=0.032) and TSH (Z=2.827, P=0.005), but lower levels of hemoglobin (t=2.616,
P=0.011), pre- albumin (t=2.515, P=0.014), albumin (t=2.643, P=0.010), FT3 (t=4.581, P＜0.001) and FT4
(t=3.693, P＜0.001), as compared with those in the patients without left ventricular hypertrophy. Binary logistic analysis showed that hemoglobin (B=0.034, OR=0.967, 95% CI 0.939～0.995, P=0.022), FT3 (B=1.195,
OR=0.303, 95% CI 0.128～0.713, P=0.006) and FT4 (B=0.427, OR=0.653, 95% CI 0.487～0.875, P=0.004)
were the protective factor for patients to have normal left ventricular thickness. Conclusion Lower FT3 and
higher TSH are common in MHD patients, and are the risk factors for left ventricular hypertrophy in MHD patients.
[1] Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012,379(9818):815-822.
[2] Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases[J]. J Am Coll Cardiol, 2018,71(16):1781-1796.
[3] Mohamedali M, Reddy Maddika S, Vyas A, et al. Thyroid disorders and chronic kidney disease[J]. Int J Nephrol, 2014,2014:520281.
[4] 赵璐杰, 李超林. 终末期肾脏病患者甲状腺功能的变化[J]. 中国血液净化,2012,11(8):436-438.
[5] Dousdampanis P, Trigka K, Vagenakis GA, Fourtounas C. The thyroid and the kidney: a complex interplay in health and disease. Int J Artif Organs. 2014. 37(1): 1-12.
[6] 刘娟, 刘伟, 李代红, 谢丽莉, 高强. 甲状腺激素水平与移植肾功能关系的临床研究. 中华器官移植杂志. 2013. 34(1): 9-12.
[7] Horá?ek J, Dusilová Sulková S, Kubi?ová M, et al. Thyroid hormone abnormalities in hemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality. Physiol Res. 2012. 61(5): 495-501.
[8] 董松, 张熙洋, 蒋秋明, 林昕. 维持性血液透析患者甲状腺功能异常的临床特征. 山东医药. 2014. (37): 33-35.
[9] Fr?czek MM, Gackowski A, Przybylik-Mazurek E, et al. [The relation between the low T3 syndrome in the clinical course of myocardial infarction and heart failure][J]. Pol Merkur Lekarski, 2016,40(240):380-383.
[10] Rhee CM, Curhan GC, Alexander EK, et al. Subclinical hypothyroidism and survival: the effects of heart failure and race[J]. J Clin Endocrinol Metab, 2013,98(6):2326-2336.
[11] Liu T, Guan Y, Li J, et al. Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis[J]. Medicine (Baltimore), 2020,99(47):e23218.
[12] Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts[J]. Circulation, 2012,126(9):1040-1049.
[13] Bajaj S, Purwar N, Gupta A, et al. Prevalence of hypothyroidism in nondiabetic chronic kidney disease and effect of thyroxine replacement on estimated glomerular filtration rate[J]. Indian J Nephrol, 2017,27(2):104-107.
[14] Shin DH, Lee MJ, Lee HS, et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism[J]. Thyroid, 2013,23(6):654-661.
